|
1
|
Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864.
|
Biochem Biophys Res Commun
|
1993
|
0.90
|
|
2
|
Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats.
|
J Cardiovasc Pharmacol
|
1997
|
0.84
|
|
3
|
In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202.
|
J Pharmacol Exp Ther
|
1993
|
0.84
|
|
4
|
Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation.
|
J Pharmacol Exp Ther
|
1991
|
0.79
|
|
5
|
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization.
|
J Med Chem
|
1999
|
0.78
|
|
6
|
Cardiovascular and antilipolytic effects of the adenosine agonist GR79236.
|
Pharmacology
|
1995
|
0.76
|
|
7
|
Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors.
|
Bioorg Med Chem Lett
|
1999
|
0.75
|
|
8
|
Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
|
Bioorg Med Chem Lett
|
2000
|
0.75
|